Statin therapy: New therapy for cardiac microvascular dysfunction

European Heart Journal

Volumn 24, Issue 22, 2003, Pages 1993-1994

  Rosenson, Robert S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STATINE DERIVATIVE;

BLOOD FLOW VELOCITY; BLOOD VISCOSITY; CORONARY BLOOD VESSEL; EDITORIAL; ELECTROCARDIOGRAPHY MONITORING; EXERCISE TOLERANCE; HEART MUSCLE ISCHEMIA; MICROVASCULATURE; POSTMENOPAUSE; PRIORITY JOURNAL; SYNDROME X; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANTICHOLESTEREMIC AGENTS; ENDOTHELIUM, VASCULAR; HUMANS; MICROVASCULAR ANGINA; PRAVASTATIN;

EID: 0242570639     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.08.005     Document Type: Editorial

References (5)

1. Panting JR, Gatehouse PD, Yang GZ et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-53.
2. Piatti P, Fragasso G, Monti LD et al. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothetial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2003;107:429-36.
3. Kayikcioglu M, Payzin S, Yavuzgil O et al. Benefits of statin treatment in cardiac syndrome-X. Euro Heart J 2003;24:1999-2005.
4. Rosenson RS. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis. In press.
5. Rosenson RS. Lipid-lowering drugs and rheology. In: Gaw A, Shepherd J, editors. Lipids and Atherosclerosis Annual 2. London: Martin Dunitz Limited; 2003, p. 19-35.